Literature DB >> 25477423

Oxygen delivery-utilization mismatch in contracting locomotor muscle in COPD: peripheral factors.

Wladimir M Medeiros1, Mari C T Fernandes1, Diogo P Azevedo1, Flavia F M de Freitas1, Beatriz C Amorim1, Luciana D Chiavegato1, Daniel M Hirai2, Denis E O'Donnell3, J Alberto Neder4.   

Abstract

Central cardiorespiratory and gas exchange limitations imposed by chronic obstructive pulmonary disease (COPD) impair ambulatory skeletal muscle oxygenation during whole body exercise. This investigation tested the hypothesis that peripheral factors per se contribute to impaired contracting lower limb muscle oxygenation in COPD patients. Submaximal neuromuscular electrical stimulation (NMES; 30, 40, and 50 mA at 50 Hz) of the quadriceps femoris was employed to evaluate contracting skeletal muscle oxygenation while minimizing the influence of COPD-related central cardiorespiratory constraints. Fractional O₂ extraction was estimated by near-infrared spectroscopy (deoxyhemoglobin/myoglobin concentration; deoxy-[Hb/Mb]), and torque output was measured by isokinetic dynamometry in 15 nonhypoxemic patients with moderate-to-severe COPD (SpO2 = 94 ± 2%; FEV₁ = 46.4 ± 10.1%; GOLD II and III) and in 10 age- and gender-matched sedentary controls. COPD patients had lower leg muscle mass than controls (LMM = 8.0 ± 0.7 kg vs. 8.9 ± 1.0 kg, respectively; P < 0.05) and produced relatively lower absolute and LMM-normalized torque across the range of NMES intensities (P < 0.05 for all). Despite producing less torque, COPD patients had similar deoxy-[Hb/Mb] amplitudes at 30 and 40 mA (P > 0.05 for both) and higher deoxy-[Hb/Mb] amplitude at 50 mA (P < 0.05). Further analysis indicated that COPD patients required greater fractional O₂ extraction to produce torque (i.e., ↑Δdeoxy-[Hb/Mb]/torque) relative to controls (P < 0.05 for 40 and 50 mA) and as a function of NMES intensity (P < 0.05 for all). The present data obtained during submaximal NMES of small muscle mass indicate that peripheral abnormalities contribute mechanistically to impaired contracting skeletal muscle oxygenation in nonhypoxemic, moderate-to-severe COPD patients.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  chronic obstructive pulmonary disease; exercise; near-infrared spectroscopy; neuromuscular electrical stimulation; skeletal muscle; torque

Mesh:

Substances:

Year:  2014        PMID: 25477423     DOI: 10.1152/ajpregu.00404.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration.

Authors:  Jayson R Gifford; Joel D Trinity; Gwenael Layec; Ryan S Garten; Song-Young Park; Matthew J Rossman; Steen Larsen; Flemming Dela; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Passive leg movement in chronic obstructive pulmonary disease: evidence of locomotor muscle vascular dysfunction.

Authors:  Stephen J Ives; Gwenael Layec; Corey R Hart; Joel D Trinity; Jayson R Gifford; Ryan S Garten; Melissa A H Witman; Jacob R Sorensen; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

3.  High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients.

Authors:  Diego de Paiva Azevedo; Wladimir Musetti Medeiros; Flávia Fernandes Manfredi de Freitas; Cesar Ferreira Amorim; Ana Cristina Oliveira Gimenes; Jose Alberto Neder; Luciana Dias Chiavegato
Journal:  Eur J Appl Physiol       Date:  2016-07-28       Impact factor: 3.078

4.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

5.  Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Authors:  Jayson R Gifford; Joel D Trinity; Oh-Sung Kwon; Gwenael Layec; Ryan S Garten; Song-Young Park; Ashley D Nelson; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-12-28

6.  A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease.

Authors:  Keisuke Miki; Seigo Kitada; Mari Miki; Shu-Ping Hui; Rojeet Shrestha; Kenji Yoshimura; Kazuyuki Tsujino; Hiroyuki Kagawa; Yohei Oshitani; Hiroshi Kida; Ryoji Maekura; Kenji Kangawa
Journal:  J Physiol Sci       Date:  2019-10-08       Impact factor: 2.781

7.  Effect of high flow nasal cannula on peripheral muscle oxygenation and hemodynamic during paddling exercise in patients with chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Tien-Pei Fang; Yen-Huey Chen; Hsiu-Feng Hsiao; Hsiu-Ying Cho; Ying-Huang Tsai; Chung-Chi Huang; Meng-Jer Hsieh; Huang-Pin Wu; Hui-Ling Lin
Journal:  Ann Transl Med       Date:  2020-03

8.  Quadriceps physiological response during the 1-min sit-to-stand test in people with severe COPD and healthy controls.

Authors:  Sarah Gephine; Patrick Mucci; Mathieu Bielmann; Mickael Martin; Laurent Bouyer; Didier Saey; François Maltais
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.